Which agent has the brand name Actemra?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Enhance your dermatological knowledge with the Dermatology Week 1 Exam. Engage with multiple choice questions that provide insights and detailed explanations to gear you up for testing success. Prepare effectively for your exam!

Multiple Choice

Which agent has the brand name Actemra?

Explanation:
Actemra is the brand name for tocilizumab, a monoclonal antibody that blocks the interleukin-6 (IL-6) receptor, preventing IL-6 signaling in inflammatory pathways. This mechanism underpins its use in conditions like rheumatoid arthritis and other IL-6–mediated diseases. The other agents listed target different cytokines or receptors—anakinra blocks the IL-1 receptor, secukinumab inhibits IL-17A, and ustekinumab blocks IL-12/23—so Actemra specifically identifies tocilizumab.

Actemra is the brand name for tocilizumab, a monoclonal antibody that blocks the interleukin-6 (IL-6) receptor, preventing IL-6 signaling in inflammatory pathways. This mechanism underpins its use in conditions like rheumatoid arthritis and other IL-6–mediated diseases. The other agents listed target different cytokines or receptors—anakinra blocks the IL-1 receptor, secukinumab inhibits IL-17A, and ustekinumab blocks IL-12/23—so Actemra specifically identifies tocilizumab.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy